Study of Anitocabtagene-autoleucel in Relapsed or Refractory Multiple Myeloma (iMMagine-1)
NCT05396885
·
clinicaltrials.gov ↗
PHASE2
Phase
ACTIVE_NOT_RECRUITING
Status
136
Enrollment
INDUSTRY
Sponsor class
Conditions
Multiple Myeloma
Interventions
BIOLOGICAL:
anitocabtagene-autoleucel
Sponsor
Kite, A Gilead Company
Collaborators
[object Object]